701 related articles for article (PubMed ID: 32551855)
1. Effects of Gene-Eden-VIR and Novirin on SARS-CoV: Implications for COVID-19.
Polansky H; Lori G
J Evid Based Integr Med; 2020; 25():2515690X20932523. PubMed ID: 32551855
[TBL] [Abstract][Full Text] [Related]
2. Coronavirus disease 2019 (COVID-19): first indication of efficacy of Gene-Eden-VIR/Novirin in SARS-CoV-2 infection.
Polansky H; Lori G
Int J Antimicrob Agents; 2020 Jun; 55(6):105971. PubMed ID: 32283177
[No Abstract] [Full Text] [Related]
3. Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and famciclovir.
Polansky H; Javaherian A; Itzkovitz E
Drug Des Devel Ther; 2016; 10():2713-22. PubMed ID: 27621592
[TBL] [Abstract][Full Text] [Related]
4. Clinical Trial of Herbal Treatment Gene-Eden-VIR/Novirin in Oral Herpes.
Polansky H; Javaherian A; Itzkovitz E
J Evid Based Integr Med; 2018; 23():2515690X18806269. PubMed ID: 30362389
[TBL] [Abstract][Full Text] [Related]
5. Lithium for the 2019 novel coronavirus.
Gómez-Bernal G
Med Hypotheses; 2020 Sep; 142():109822. PubMed ID: 32408073
[No Abstract] [Full Text] [Related]
6. Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.
Ayaz S; Crea F
Epigenomics; 2020 May; 12(10):811-812. PubMed ID: 32495654
[No Abstract] [Full Text] [Related]
7. Shedding Light on the Effect of Natural Anti-Herpesvirus Alkaloids on SARS-CoV-2: A Treatment Option for COVID-19.
Hassan STS
Viruses; 2020 Apr; 12(4):. PubMed ID: 32340120
[TBL] [Abstract][Full Text] [Related]
8. Understanding COVID-19: From Origin to Potential Therapeutics.
Moazzam M; Sajid MI; Shahid H; Butt J; Bashir I; Jamshaid M; Shirazi AN; Tiwari RK
Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32823901
[TBL] [Abstract][Full Text] [Related]
9. [SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19].
Ladoux A; Azoulay S; Dani C
Med Sci (Paris); 2020; 36(6-7):555-558. PubMed ID: 32558640
[No Abstract] [Full Text] [Related]
10. Human papillomavirus (HPV): systemic treatment with Gene-Eden-VIR/Novirin safely and effectively clears virus.
Polansky H; Itzkovitz E; Javaherian A
Drug Des Devel Ther; 2017; 11():575-583. PubMed ID: 28424535
[TBL] [Abstract][Full Text] [Related]
11. Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19).
Yuan S; Chan CC; Chik KK; Tsang JO; Liang R; Cao J; Tang K; Cai JP; Ye ZW; Yin F; To KK; Chu H; Jin DY; Hung IF; Yuen KY; Chan JF
Viruses; 2020 Jun; 12(6):. PubMed ID: 32532085
[TBL] [Abstract][Full Text] [Related]
12. Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co-infection with HIV: clinical case series analysis in North Central Nigeria.
Akyala AI; Iwu CJ
Pan Afr Med J; 2020; 37():47. PubMed ID: 33209174
[TBL] [Abstract][Full Text] [Related]
13. Structural Biology Aids the Research of New Anti-COVID-19 Drugs.
Lu J; Liu X
Curr Org Synth; 2020; 17(3):162-163. PubMed ID: 32538717
[No Abstract] [Full Text] [Related]
14. Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review.
Santos J; Brierley S; Gandhi MJ; Cohen MA; Moschella PC; Declan ABL
Viruses; 2020 Jun; 12(7):. PubMed ID: 32629804
[TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.
Shi D; Wu W; Wang Q; Xu K; Xie J; Wu J; Lv L; Sheng J; Guo J; Wang K; Fang D; Li Y; Li L
J Infect Dis; 2020 Aug; 222(6):910-918. PubMed ID: 32614392
[TBL] [Abstract][Full Text] [Related]
16. Repurposing old drugs as antiviral agents for coronaviruses.
Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
[TBL] [Abstract][Full Text] [Related]
17. Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19).
Khodadadi E; Maroufi P; Khodadadi E; Esposito I; Ganbarov K; Espsoito S; Yousefi M; Zeinalzadeh E; Kafil HS
Microb Pathog; 2020 Sep; 146():104241. PubMed ID: 32387389
[TBL] [Abstract][Full Text] [Related]
18. Novel Coronavirus (SARS-CoV-2) resistance in African populations: A cause worth exploring.
Krishan K; Kanchan T
Acta Biomed; 2020 Sep; 91(3):e2020023. PubMed ID: 32921745
[TBL] [Abstract][Full Text] [Related]
19. Cautions and Opportunities for Botanicals in COVID-19 Patients: A Comment on the Position of the French Agency for Food, Environmental and Occupational Health & Safety.
Firenzuoli F; Antonelli M; Donelli D; Gensini GF; Maggini V
J Altern Complement Med; 2020 Oct; 26(10):851-853. PubMed ID: 32960104
[No Abstract] [Full Text] [Related]
20. [Not Available].
Nau JY
Rev Med Suisse; 2020 Mar; 16(685):510-511. PubMed ID: 32167254
[No Abstract] [Full Text] [Related]
[Next] [New Search]
